iCell Therapeutics, Inc.

iCell Therapeutics is a dynamic biotechnology company dedicated to establishing new standards of care in oncology and cardiovascular treatments. iCell's nano sized technology is a low density emulsion, named LDE, with particles similar to the structure of low-density lipoprotein (LDL) which acquires the apo E while in the plasma, thus becoming capable of targeting and binding to the specific receptors of LDL existing on the surface of cellular membranes.

Website